Meiji Yasuda Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,986	Closed	-$536K	–	546
2025 Q1	$536K	Hold	1,986	–	–	0.02%	423
2024 Q4	$467K	Hold	1,986	–	–	0.02%	450
2024 Q3	$546K	Sell	1,986 -44	-2%	-$11.5K	0.02%	422
2024 Q2	$493K	Buy	2,030 +270	+15%	+$42.6K	0.02%	430
2024 Q1	$263K	Buy	1,760 +380	+28%	+$63.4K	0.01%	573
2023 Q4	$264K	Hold	1,380	–	–	0.01%	485
2023 Q3	$244K	Buy	1,380 +160	+13%	+$30.5K	0.01%	553
2023 Q2	$232K	Hold	1,220	–	–	0.01%	557
2023 Q1	$244K	Buy	1,220 +50	+4%	+$10.5K	0.01%	534
2022 Q4	$278	Sell	1,170 -50	-4%	-$10.7K	0.01%	525
2022 Q3	$244K	Sell	1,220 -190	-13%	-$36.2K	0.01%	538
2022 Q2	$206K	Buy	1,410 +160	+13%	+$22.7K	0.01%	600
2022 Q1	$204K	Sell	1,250 -150	-11%	-$22.9K	0.01%	601
2021 Q4	$237K	Buy	1,400 +160	+13%	+$29.7K	0.01%	501
2021 Q3	$234K	Buy	1,240 +60	+5%	+$11.3K	0.02%	473
2021 Q2	$200K	Buy	+1,180	New	+$173K	0.01%	510
2020 Q3	–	Sell	-1,470	Closed	-$218K	–	374
2020 Q2	$218K	Buy	+1,470	New	+$198K	0.02%	444